Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Total GTN reserves (FY2013–FY2017) by Year
Total GTN reserves (FY2013–FY2017) — Credits and payments made ($M) ($M)
Vertex Pharmaceuticals Total GTN reserves (FY2013–FY2017): -$179M in FY2017, up 44.8% from a year earlier. No newer figure appears in the documents we track.
Where the FY2017 figure comes from
“|| Credits/payments made | (25,507 | ) | (137,765 | ) | (4,496 | ) | (11,633 | ) | (179,401 | )”
Source: Form 10-K (a201710k-main.htm, filed 2018-02-15) ↗
Reported in Form 10-K MD&A (FY2015–FY2017).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total GTN reserves (FY2013–FY2017) — Credits and payments made ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2017 | Dec 31, 2017 | -179 | +44.8% | Form 10-K (a201710k-main.htm, filed 2018-02-15) ↗ |
| FY2016 | Dec 31, 2016 | -124 | +163.1% | Form 10-K (a201710k-main.htm, filed 2018-02-15) ↗ |
| FY2015 | Dec 31, 2015 | -47.1 | -54.0% | Form 10-K (a201710k-main.htm, filed 2018-02-15) ↗ |
| FY2014 | Dec 31, 2014 | -102 | -60.4% | Form 10-K (a201610k-main.htm, filed 2017-02-23) ↗ |
| FY2013 | Dec 31, 2013 | -259 | – | Form 10-K (a201510k-main.htm, filed 2016-02-16) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Total GTN reserves (FY2013–FY2017) ($M), annual FY2013–FY2017 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/gtn-total-credits-paid
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.